Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-platform comparison of gene expression-based cancer molecular subtyping reveals discrepancies with exome capture methods.

NPJ precision oncology·2025
Same author

Plasma Circulating HPV DNA Surveillance in a Patient With Nasopharyngeal Cancer.

Ear, nose, & throat journal·2024
Same author

Purity Independent Subtyping of Tumors (PurIST) Pancreatic Cancer Classifier: Analytic Validation of a 16-RNA Expression Signature Distinguishing Basal and Classical Subtypes.

The Journal of molecular diagnostics : JMD·2024
Same author

EBV-Associated Gastric Cancer; An In Situ Hybridization Assay on Tissue Microarray: A Multi-Region Study from Four Major Provinces of Iran.

Archives of Iranian medicine·2024
Same author

Calibration of cell-free DNA measurements by next-generation sequencing.

American journal of clinical pathology·2023
Same author

The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.

BMC cancer·2022

Related Experiment Video

Updated: Jun 25, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

A rational approach to genetic testing for sarcoma.

Margaret L Gulley1, Kathleen A Kaiser-Rogers

  • 1Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599-7525, USA. margaret_gulley@med.unc.edu

Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|February 14, 2009
PubMed
Summary
This summary is machine-generated.

Modern molecular diagnostics are crucial for sarcoma identification, guiding treatment decisions. Pathologists play a key role in selecting appropriate tests and interpreting genetic findings for optimal patient management.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Related Experiment Videos

Last Updated: Jun 25, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Area of Science:

  • Oncology
  • Genetics
  • Molecular Pathology

Background:

  • Sarcoma diagnosis increasingly depends on molecular genetic testing.
  • Different molecular assays have unique tissue requirements and applications.
  • Genetic defects serve as tumor markers for staging and therapy monitoring.

Purpose of the Study:

  • To highlight the importance of molecular diagnostics in sarcoma.
  • To discuss the advantages and limitations of various analytic methods.
  • To emphasize the pathologist's role in guiding molecular testing and clinical management.

Main Methods:

  • Karyotyping for genome-wide chromosomal alterations.
  • Fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR) for specific genetic defects.
  • Array-based methods for identifying genes and pathways involved in tumor growth.

Main Results:

  • Specific genetic alterations like EWSR1-FLI1, SS18-SSX1, PAX3-FOXO1A, and MYCN amplification are characteristic of certain sarcomas.
  • Array-based research is driving the development of targeted diagnostic panels.
  • Pathologist expertise is vital for specimen handling, test selection, and result interpretation.

Conclusions:

  • Accurate sarcoma diagnosis and management rely on judicious use of molecular technologies.
  • Pathologists are essential in integrating molecular findings into clinical decision-making.
  • Continued research in molecular diagnostics promises improved pharmacogenetic testing and targeted therapies.